Viewing Study NCT07178457


Ignite Creation Date: 2025-12-24 @ 6:36 PM
Ignite Modification Date: 2026-04-17 @ 5:20 AM
Study NCT ID: NCT07178457
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-17
First Post: 2025-08-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Brentuximab Vedotin in CutAneous T-cell Lymphomas (CTCL): Post-allogeneic Hematopoietic Stem Cell Transplant Maintenance
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module